` HBC (Hofseth Biocare ASA) vs Oslo OBX Comparison - Alpha Spread

HBC
vs
Oslo OBX

Over the past 12 months, HBC has underperformed Oslo OBX, delivering a return of -29% compared to the Oslo OBX's 16% growth.

Stocks Performance
HBC vs Oslo OBX

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
HBC vs Oslo OBX

Loading
HBC
Oslo OBX
Difference

Performance By Year
HBC vs Oslo OBX

Loading
HBC
Oslo OBX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Hofseth Biocare ASA vs Peers

Oslo OBX
HBC
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Hofseth Biocare ASA
Glance View

Market Cap
762.6m NOK
Industry
Biotechnology

Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. The company is headquartered in Alesund, More Og Romsdal and currently employs 63 full-time employees. The company went IPO on 2011-12-02. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.

HBC Intrinsic Value
4.172 NOK
Undervaluation 56%
Intrinsic Value
Price
Back to Top